NEW YORK (GenomeWeb News) – Life Technologies and OpGen today said that they will co-develop technologies and applications for public health surveillance.

The companies plan to incorporate Life Tech's Ion Torrent sequencing system with OpGen's whole-genome mapping technology. They will focus on developing technologies and applications to improve the management and surveillance of food-borne microbial outbreaks and infectious disease analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.